
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.05 | -3.7037037037 | 1.35 | 1.405 | 1.2308 | 825010 | 1.28596028 | CS |
4 | 0 | 0 | 1.3 | 1.695 | 1.22 | 974200 | 1.4383394 | CS |
12 | 0 | 0 | 1.3 | 1.72 | 1.1001 | 976952 | 1.41182427 | CS |
26 | -12.04 | -90.2548725637 | 13.34 | 14.255 | 1.1001 | 1762156 | 2.79017524 | CS |
52 | -9.86 | -88.3512544803 | 11.16 | 16.1 | 1.1001 | 1114083 | 5.13111798 | CS |
156 | -7.08 | -84.4868735084 | 8.38 | 36.64 | 1.1001 | 891579 | 14.33225656 | CS |
260 | -28.69 | -95.6652217406 | 29.99 | 43.92 | 1.1001 | 586908 | 14.89441123 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions